- Previous Close
14.62 - Open
14.54 - Bid 14.38 x --
- Ask 14.76 x --
- Day's Range
14.24 - 14.84 - 52 Week Range
12.42 - 37.50 - Volume
7,223 - Avg. Volume
21,752 - Market Cap (intraday)
1.235B - Beta (5Y Monthly) 0.80
- PE Ratio (TTM)
-- - EPS (TTM)
-3.10 - Earnings Date Feb 27, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharmaceutical and biotech industry in Europe and the United States. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients, as well as designs and develops nanoformed drug substance. It also offers STARMAP, as a secure online portal to perform large numbers of in-silico CESS experiments The company was founded in 2008 and is headquartered in Helsinki, Finland.
www.nanoform.comRecent News: NANOFS.ST
View MorePerformance Overview: NANOFS.ST
Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NANOFS.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NANOFS.ST
View MoreValuation Measures
Market Cap
1.23B
Enterprise Value
768.96M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
43.21
Price/Book (mrq)
1.63
Enterprise Value/Revenue
27.57
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-17.58%
Return on Equity (ttm)
-29.49%
Revenue (ttm)
2.3M
Net Income Avi to Common (ttm)
-21.67M
Diluted EPS (ttm)
-3.10
Balance Sheet and Cash Flow
Total Cash (mrq)
51.5M
Total Debt/Equity (mrq)
8.44%
Levered Free Cash Flow (ttm)
-12.71M